市场调查报告书
商品编码
1422162
男性女乳症治疗市场 - 成长、未来前景、竞争分析,2023-2031Gynecomastia Procedures Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031 |
预计 2024 年至 2032 年预测期内,男性女乳症手术市场将以 8.5% 的复合年增长率成长。由于男性女乳症发病率上升、治疗技术的进步以及对男性美学和身体形象的日益关注等因素,男性女乳症治疗市场正在经历显着增长。然而,男性女乳症治疗的高价格是一个主要障碍。随着市场的不断发展,技术的进步和对男性美不断变化的社会态度正在导致男性女乳症手术成为寻求美容和改善身体形象的患者的安全有效的解决方案。预计将促进
男性女乳症手术市场是由全球男性女乳症病例日益普及所推动的。男性女乳症是一种常见疾病,其特征是男性乳房组织增大,通常是由荷尔蒙失衡、药物使用或潜在疾病引起的。由于生活方式的改变、久坐的生活方式和接触内分泌干扰物,男性女乳症的发生率正在增加。此外,人们对整容手术认识的提高和耻辱感的减少意味着更多的男性正在寻求男性女乳症的治疗。因此,对男性女乳症治疗的需求庞大,促进了市场成长。
男性女乳症治疗市场的成长受到治疗技术进步的影响。多年来,矫正男性女乳症的手术和非手术技术取得了重大创新。抽脂和雷射辅助溶脂等微创手术因其减少的停机时间和更好的美容效果而越来越受欢迎。此外,乳房切除术和皮肤紧緻手术等手术技术也得到了改进,以达到更自然、更美观的效果。技术进步不仅提高了患者满意度,还扩大了潜在患者基础并促进了市场成长。
对男性美和身体形象的日益关注在推动男性女乳症手术的需求方面发挥关键作用。近年来,文化发生了转变,转向拥抱身体积极性并寻求整容手术来增强自信。此外,男性现在更有可能公开表达自己对美丽的担忧,并考虑透过整容手术来实现自己想要的体型。男性女乳症手术为男性乳房增大提供了安全有效的解决方案,随着男性寻求改善外表和身体形象,男性女乳症手术的需求激增。社会对男性美的看法和接受度的变化预计将推动未来几年的市场成长。
影响男性女乳症治疗市场的重要限制因素之一是与这些治疗相关的高成本。男性女乳症可以透过手术和非手术来矫正,这两种手术都相对昂贵。手术费用包括手术费、住院费、麻醉费、术后护理费等,对病人来说是一笔重大的财务投资。此外,抽脂和雷射治疗等非手术治疗也可能非常昂贵。男性女乳症手术的高成本可能会阻止潜在患者接受治疗,从而限制市场成长。然而,医疗保健融资选择和男性女乳症治疗保险范围的进步预计将在未来解决这一限制。
根据年龄类别,市场分为 18-40 岁和 40 岁以上。40 岁以上消费者群体在 2023 年收入份额最高,预计在 2024-2032 年预测期内也将以最高复合年增长率成长。40岁以上年龄层在男性女乳症市场的主导地位可归因于荷尔蒙变化、长期危险因子的累积影响、药物使用、老年人更普遍的健康状况以及经济实力的增强。随着男性年龄的增长,荷尔蒙的变化会增加男性女乳症的风险。由于睪固酮水平下降和身体肥胖增加,老年男性更容易出现男性女乳症。同时,18至40岁的年龄组预计在预测期内也将出现强劲成长。男性女乳症在青春期很常见,此时荷尔蒙波动达到高峰。这个年龄层的特征是青春期开始,导致男性女乳症的发生率较高。此外,随着社会对男性女乳症的认知提高,18-40 岁年龄层的人更有可能因男性女乳症问题寻求医疗干预,这可能会增加市场占有率。
市场依手术类型分为抽脂和切除手术。2023年,切除手术领域将占据市场最大的收入份额。如果男性女乳症是由于腺体组织增大而不是脂肪过多引起的,那么手术切除比抽脂手术更有效。此外,去除腺体组织的手术技术的进步也促进了切除手术的兴起。外科医生现在可以使用复杂而精确的技术,可以更有效地去除腺体组织,同时最大限度地减少疤痕。这些发展增加了患者和外科医生的信心,他们相信切除手术是一种可行的治疗选择。然而,作为一种比切除手术侵入性较小的手术,抽脂术预计将在 2024 年至 2032 年的预测期内呈现最高成长率。在抽脂过程中,透过小切口插入插管,并吸出多余的脂肪。与切除手术相比,抽脂术的微创性质通常会导致更小的疤痕、更快的恢復期和更少的术后不适。
就地理细分而言,北美在 2023 年的收入方面领先男性女乳症市场。该地区的主导地位是由于男性美学意识的提高、对整容手术的接受程度不断提高以及提供男性女乳症治疗的熟练医疗保健专业人员的存在。此外,有利的医疗保健政策和整容手术保险进一步支持了北美市场的成长。同时,亚太地区预计在 2024 年至 2032 年预测期内复合年增长率最高。可支配收入的增加、对整容手术文化态度的改变以及医疗旅游业的不断发展等因素正在推动该地区男性女乳症手术的采用。此外,亚太地区人口众多且医疗基础设施不断增加,预计将有助于市场的扩张。
男性女乳症治疗市场竞争激烈,有几家大公司在全球营运。市场主要参与者包括Allergan, Inc. AbbVie Inc.、Sientra, Inc.、Bausch Health Companies Inc.、Teva Pharmaceutical Industries Ltd.、Johnson &Johnson Services, Inc.、Cadila Pharmaceuticals Ltd.、Sun Pharmaceuticals Industries Ltd.、Zydus Cadila Healthcare Ltd.、Biochem Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd.、Micro Nova Pharmaceuticals Ltd.、Kee Pharma Ltd.等。这些公司在全球拥有强大的影响力,并提供广泛的男性女乳症治疗选择。为了保持竞争力,这些公司专注于研究和开发,以改善治疗效果、扩大产品组合併提高患者安全。此外,我们正在积极发展策略行销和合作伙伴关係,以提高市场渗透率并加强我们的全球足迹。截至 2023 年,男性女乳症手术市场正在经历显着成长,这些主要参与者正在利用市场机会。展望2024年至2032年的预测期,这些参与者预计将继续主导市场,并透过不断的创新和策略举措推动市场成长。
The gynecomastia procedures market is expected to grow at a CAGR of 8.5% during the forecast period of 2024 to 2032. The gynecomastia procedures market has experienced significant growth due to factors such as the rising prevalence of gynecomastia cases, advancements in treatment technologies, and increasing focus on male aesthetics and body image. However, the high cost of gynecomastia procedures poses a significant restraint. As the market continues to evolve, technological advancements and evolving societal attitudes towards male aesthetics are expected to fuel the adoption of gynecomastia procedures as a safe and effective solution for patients seeking cosmetic enhancement and improved body image.
The gynecomastia procedures market has been driven by the increasing prevalence of gynecomastia cases worldwide. Gynecomastia is a common condition characterized by the enlargement of male breast tissue, often resulting from hormonal imbalances, medication use, or underlying medical conditions. With changing lifestyles, sedentary habits, and exposure to endocrine-disrupting substances, the incidence of gynecomastia has been on the rise. Additionally, increasing awareness and reduced stigma associated with cosmetic procedures have encouraged more men to seek treatment for gynecomastia. As a result, there has been a significant demand for gynecomastia procedures, contributing to the growth of the market.
The growth of the gynecomastia procedures market has been influenced by advancements in treatment technologies. Over the years, there have been significant innovations in surgical and non-surgical techniques for gynecomastia correction. Minimally invasive procedures, such as liposuction and laser-assisted lipolysis, have gained popularity due to their reduced downtime and better cosmetic outcomes. Additionally, surgical techniques, such as glandular excision and skin tightening procedures, have been refined to achieve more natural and aesthetically pleasing results. Technological advancements have not only improved patient satisfaction but have also expanded the potential patient pool, contributing to the market's growth.
The increasing focus on male aesthetics and body image has played a significant role in driving the demand for gynecomastia procedures. In recent years, there has been a cultural shift towards embracing body positivity and seeking cosmetic enhancements to boost self-confidence. Men are now more open to discussing their aesthetic concerns and considering cosmetic procedures to achieve their desired physique. Gynecomastia procedures, which provide a safe and effective solution for addressing male breast enlargement, have witnessed a surge in demand as men seek to improve their appearance and body image. This changing societal perception and acceptance of male aesthetics are expected to drive the market's growth in the coming years.
One significant restraint that has affected the gynecomastia procedures market is the high cost associated with these treatments. Gynecomastia correction involves surgical and non-surgical procedures, both of which can be relatively expensive. The cost of surgery includes surgeon fees, hospitalization expenses, anesthesia costs, and post-operative care, making it a significant financial investment for patients. Additionally, non-surgical procedures, such as liposuction and laser treatments, also come with considerable costs. The high cost of gynecomastia procedures may deter some potential patients from seeking treatment, limiting the market's growth. However, advancements in healthcare financing options and insurance coverage for gynecomastia treatments are expected to address this restraint in the future.
Based on age category, the market has been segmented into those aged 18 to 40 and those aged over 40. With the highest revenue share in 2023, the segment of consumers aged 40 and older is also expected to grow at the highest CAGR during the forecast period of 2024 to 2032. The dominance of the over-40 age group in the gynecomastia market can be attributed to hormonal changes, the cumulative effects of risk factors over time, medication use, health conditions prevalent in older individuals, and increased financial capability. Hormonal changes occur in men as they age, which increases their risk of developing gynecomastia. Elderly men are more susceptible to gynecomastia due to the decline in testosterone levels and the increase in body obesity. On the other hand, it is anticipated that the 18-to-40 age group will also experience robust growth over the forecast period. Gynecomastia is common during puberty when hormonal fluctuations are at their zenith. This age group is characterized by the onset of puberty, resulting in a higher incidence of gynecomastia cases. In addition, as societal awareness of gynecomastia increases, individuals in the 18-to-40 age range may be more likely to seek medical intervention for gynecomastia concerns, resulting in a larger market share.
The market has been segmented based on procedure type into liposuction and excision. In 2023, the excision procedure segment held the largest revenue share of the market. In instances where gynecomastia is caused by an enlargement of glandular tissue as opposed to superfluous fat, surgical excision is more effective than liposuction. In addition, advances in surgical techniques for glandular tissue excision have contributed to the growing prominence of excision surgery. Surgeons now have access to refined and accurate techniques that enable more effective glandular tissue removal with minimal scarring. These developments have increased patients' and surgeons' confidence in excision surgery as a viable treatment option. As a less invasive procedure than excision surgery, however, liposuction is anticipated to experience the highest growth rate over the forecast period of 2024 to 2032. Through tiny incisions, cannulas are inserted to suction out excess fat during liposuction. In comparison to excision surgery, the minimally invasive nature of liposuction often results in smaller scars, faster recovery periods, and less post-operative discomfort.
In terms of geographic segmentation, North America was leading the market for gynecomastia in terms of revenues in 2023. The region's dominance can be attributed to the increasing awareness of male aesthetics, greater acceptance of cosmetic procedures, and the presence of skilled healthcare professionals offering gynecomastia treatments. Additionally, favorable healthcare policies and insurance coverage for cosmetic procedures further support the market's growth in North America. Meanwhile, the Asia-Pacific region is anticipated to experience the highest CAGR during the forecast period of 2024 to 2032. Factors such as rising disposable income, changing cultural attitudes towards cosmetic enhancements, and a growing medical tourism industry are driving the adoption of gynecomastia procedures in the region. Moreover, the presence of a large population base and increasing healthcare infrastructure are expected to contribute to the market's expansion in Asia-Pacific.
The gynecomastia procedures market is competitive, with several key players operating in the global landscape. Some of the top players in the market include Allergan, Inc. (AbbVie Inc.), Sientra, Inc., Bausch Health Companies Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Zydus Cadila Healthcare Ltd, Biochem Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Micro Nova Pharmaceuticals Ltd and Kee Pharma Ltd. These companies have a strong global presence and offer a wide range of gynecomastia treatment options. To maintain their competitive edge, these players focus on research and development to improve treatment outcomes, expand their product portfolios, and enhance patient safety. Additionally, they actively engage in strategic marketing and partnerships to increase market penetration and strengthen their global footprint. As of 2023, the gynecomastia procedures market has witnessed substantial growth, and these top players have capitalized on market opportunities. Looking ahead to the forecast period from 2024 to 2032, it is expected that these players will continue to dominate the market and drive its growth through continued innovation and strategic initiatives.
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofGynecomastia Procedures market are as follows:
Number of end users and consumption volume, price and value.
Micro and macro environment factors that are currently influencing the Gynecomastia Procedures market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Estimated forecast and market projections up to 2031.
FIG. 10Market Positioning of Key Gynecomastia Procedures Market Players, 2023
FIG. 11Global Gynecomastia Procedures Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032